Clinical Trial: Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668856) titled 'Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials' on March 25.

Brief Summary: The goal of this clinical trial is to learn if cannabidiol ("CBD-oil") works to treat severe epilepsy in children. It will also learn about the safety of cannabidiol. The main questions it aims to answer are:

* Does cannabidiol lower the number of seizure in children with severe epilepsy?

* Does cannabidiol effect other outcomes such as behaviour, sleep, communication, activities?

* What medical problems do participants have when taking cannabidiol?

Resea...